Literature DB >> 11816811

Process development and metabolic engineering for the overproduction of natural and unnatural polyketides.

R McDaniel1, P Licari, C Khosla.   

Abstract

Polyketide natural products are a rich source of bioactive substances that have found considerable use in human health and agriculture. Their complex structures require that they be produced via fermentation processes. This review describes the strategies and challenges used to develop practical fermentation strains and processes for polyketide production. Classical strain improvement procedures, process development methods, and metabolic engineering approaches are described. The elucidation of molecular mechanisms that underlie polyketide biosynthesis has played an important role in each of these areas over the past few years.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11816811     DOI: 10.1007/3-540-45300-8_3

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  7 in total

1.  Joint engineering of SACE_Lrp and its target MarR enhances the biosynthesis and export of erythromycin in Saccharopolyspora erythraea.

Authors:  Jing Liu; Long Li; Yunxia Wang; Bowen Li; Xinlu Cai; Lijuan Tang; Shengnan Dong; Endong Yang; Hang Wu; Buchang Zhang
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-24       Impact factor: 4.813

2.  Engineering of the methylmalonyl-CoA metabolite node of Saccharopolyspora erythraea for increased erythromycin production.

Authors:  Andrew R Reeves; Igor A Brikun; William H Cernota; Benjamin I Leach; Melissa C Gonzalez; J Mark Weber
Journal:  Metab Eng       Date:  2007-03-24       Impact factor: 9.783

3.  Comparative genomics and transcriptional profiles of Saccharopolyspora erythraea NRRL 2338 and a classically improved erythromycin over-producing strain.

Authors:  Clelia Peano; Adelfia Talà; Giorgio Corti; Daniela Pasanisi; Miriana Durante; Giovanni Mita; Silvio Bicciato; Gianluca De Bellis; Pietro Alifano
Journal:  Microb Cell Fact       Date:  2012-03-08       Impact factor: 5.328

4.  Strain improvement and optimization studies for enhanced production of erythromycin in bagasse based medium using Saccharopolyspora erythraea MTCC 1103.

Authors:  C Subathra Devi; Anuj Saini; Shubham Rastogi; S Jemimah Naine; V Mohanasrinivasan
Journal:  3 Biotech       Date:  2013-12-18       Impact factor: 2.406

5.  Systems perspectives on erythromycin biosynthesis by comparative genomic and transcriptomic analyses of S. erythraea E3 and NRRL23338 strains.

Authors:  Yuan-Yuan Li; Xiao Chang; Wen-Bang Yu; Hao Li; Zhi-Qiang Ye; Hui Yu; Bao-Hong Liu; Yan Zhang; Si-Liang Zhang; Bang-Ce Ye; Yi-Xue Li
Journal:  BMC Genomics       Date:  2013-07-31       Impact factor: 3.969

6.  Inactivation of SACE_3446, a TetR family transcriptional regulator, stimulates erythromycin production in Saccharopolyspora erythraea.

Authors:  Hang Wu; Yansheng Wang; Li Yuan; Yongrong Mao; Weiwei Wang; Lin Zhu; Panpan Wu; Chengzhang Fu; Rolf Müller; David T Weaver; Lixin Zhang; Buchang Zhang
Journal:  Synth Syst Biotechnol       Date:  2016-02-16

7.  Phenotypes and gene expression profiles of Saccharopolyspora erythraea rifampicin-resistant (rif) mutants affected in erythromycin production.

Authors:  Elisabetta Carata; Clelia Peano; Salvatore M Tredici; Francesco Ferrari; Adelfia Talà; Giorgio Corti; Silvio Bicciato; Gianluca De Bellis; Pietro Alifano
Journal:  Microb Cell Fact       Date:  2009-03-30       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.